AurKa Pharma Inc. Report issue

For profit Phase 2
Founded: Montreal Canada (2016)
Status: Acquired by Eli Lilly (2018)

Organization Overview

First Clinical Trial
2017
NCT03092934
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree